Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Menu

    Hydrazine

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 26Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NewMarket Corp Acquires Calca Solutions, LLC
    NewMarket Corp Acquires Calca Solutions, LLC

    17 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-17/newmarket-corporation-announces-the-acquisition-of-calca-solutions-llc

    PHARMAWEB
    17 Sep 2025
    Share Share
    Global Hydrazine Market Expected to Reach $485 Million by 2022 ,Allied Market
    Global Hydrazine Market Expected to Reach $485 Million by 2022 ,Allied Market

    02 Mar 2017

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/global-hydrazine-market-expected-to-reach-485-million-by-2022---allied-market-research-615218154.html

    PR NEWSWIRE
    02 Mar 2017
    Share Share